Literature DB >> 27060854

DNA repair variants and breast cancer risk.

Anne Grundy1, Harriet Richardson2, Johanna M Schuetz3, Igor Burstyn4, John J Spinelli5,6, Angela Brooks-Wilson3,7, Kristan J Aronson2.   

Abstract

A functional DNA repair system has been identified as important in the prevention of tumour development. Previous studies have hypothesized that common polymorphisms in DNA repair genes could play a role in breast cancer risk and also identified the potential for interactions between these polymorphisms and established breast cancer risk factors such as physical activity. Associations with breast cancer risk for 99 single nucleotide polymorphisms (SNPs) from genes in ten DNA repair pathways were examined in a case-control study including both Europeans (644 cases, 809 controls) and East Asians (299 cases, 160 controls). Odds ratios in both additive and dominant genetic models were calculated separately for participants of European and East Asian ancestry using multivariate logistic regression. The impact of multiple comparisons was assessed by correcting for the false discovery rate within each DNA repair pathway. Interactions between several breast cancer risk factors and DNA repair SNPs were also evaluated. One SNP (rs3213282) in the gene XRCC1 was associated with an increased risk of breast cancer in the dominant model of inheritance following adjustment for the false discovery rate (P < 0.05), although no associations were observed for other DNA repair SNPs. Interactions of six SNPs in multiple DNA repair pathways with physical activity were evident prior to correction for FDR, following which there was support for only one of the interaction terms (P < 0.05). No consistent associations between variants in DNA repair genes and breast cancer risk or their modification by breast cancer risk factors were observed.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA repair; breast cancer; case-control study; physical activity; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2016        PMID: 27060854     DOI: 10.1002/em.22013

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

1.  Women's occupational exposure to polycyclic aromatic hydrocarbons and risk of breast cancer.

Authors:  Derrick G Lee; Igor Burstyn; Agnes S Lai; Anne Grundy; Melissa C Friesen; Kristan J Aronson; John J Spinelli
Journal:  Occup Environ Med       Date:  2019-01       Impact factor: 4.948

2.  A Polymorphism Located Near PMAIP1/Noxa Gene Influences Susceptibility to Hodgkin Lymphoma Development in South India

Authors:  Dimpal N Thakkar; Sunitha Kodidela; Selvarajan Sandhiya; Biswajit Dubashi; Steven Aibor Dkhar
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

3.  Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women.

Authors:  Junrong Wu; Min Fang; Xiaoping Zhou; Bo Zhu; Zhi Yang
Journal:  Oncotarget       Date:  2017-04-11

4.  Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls.

Authors:  Lele Qiao; Xiaoshan Feng; Gongping Wang; Bo Zhou; Yantong Yang; Mengxiang Li
Journal:  Oncotarget       Date:  2018-01-02

5.  Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development.

Authors:  Luisa Maresca; Samuele Lodovichi; Alessandra Lorenzoni; Tiziana Cervelli; Rossella Monaco; Laura Spugnesi; Mariella Tancredi; Elisabetta Falaschi; Katia Zavaglia; Elisabetta Landucci; Manuela Roncella; Caterina Congregati; Angiolo Gadducci; Antonio Giuseppe Naccarato; Maria Adelaide Caligo; Alvaro Galli
Journal:  Front Genet       Date:  2018-09-19       Impact factor: 4.599

6.  Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk.

Authors:  Johanna M Schuetz; Anne Grundy; Derrick G Lee; Agnes S Lai; Lindsay C Kobayashi; Harriet Richardson; Jirong Long; Wei Zheng; Kristan J Aronson; John J Spinelli; Angela R Brooks-Wilson
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.